SMO ClinPlus Co. Ltd. (301257) - Total Liabilities
Based on the latest financial reports, SMO ClinPlus Co. Ltd. (301257) has total liabilities worth CN¥247.77 Million CNY (≈ $36.26 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore 301257 cash flow conversion to assess how effectively this company generates cash.
SMO ClinPlus Co. Ltd. - Total Liabilities Trend (2019–2024)
This chart illustrates how SMO ClinPlus Co. Ltd.'s total liabilities have evolved over time, based on quarterly financial data. Check SMO ClinPlus Co. Ltd. (301257) asset resilience to evaluate the company's liquid asset resilience ratio.
SMO ClinPlus Co. Ltd. Competitors by Total Liabilities
The table below lists competitors of SMO ClinPlus Co. Ltd. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Happiest Minds Technologies Limited
NSE:HAPPSTMNDS
|
India | Rs18.00 Billion |
|
Pulike Biological Engineering
SHG:603566
|
China | CN¥513.09 Million |
|
Stendörren Fastigheter AB (publ)
ST:STEF-B
|
Sweden | Skr11.19 Billion |
|
Chrysos Corporation Ltd
AU:C79
|
Australia | AU$87.85 Million |
|
Amata Corporation Public Company Limited
BK:AMATA-R
|
Thailand | ฿41.39 Billion |
|
Tianjin Tianbao Infrastructure Co Ltd
SHE:000965
|
China | CN¥8.82 Billion |
|
Idaho Strategic Resources Inc
NYSE MKT:IDR
|
USA | $6.17 Million |
|
Sturm Ruger & Company Inc
NYSE:RGR
|
USA | $62.69 Million |
Liability Composition Analysis (2019–2024)
This chart breaks down SMO ClinPlus Co. Ltd.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see SMO ClinPlus Co. Ltd. stock valuation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 5.79 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.20 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.17 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how SMO ClinPlus Co. Ltd.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for SMO ClinPlus Co. Ltd. (2019–2024)
The table below shows the annual total liabilities of SMO ClinPlus Co. Ltd. from 2019 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥256.48 Million ≈ $37.53 Million |
-10.39% |
| 2023-12-31 | CN¥286.22 Million ≈ $41.88 Million |
+37.11% |
| 2022-12-31 | CN¥208.75 Million ≈ $30.55 Million |
+19.01% |
| 2021-12-31 | CN¥175.41 Million ≈ $25.67 Million |
+37.65% |
| 2020-12-31 | CN¥127.43 Million ≈ $18.65 Million |
+66.06% |
| 2019-12-31 | CN¥76.74 Million ≈ $11.23 Million |
-- |
About SMO ClinPlus Co. Ltd.
SMO ClinPlus CO.,LTD. provides site management services in research development in pharmaceuticals, medical devices, and health-related products in China. The company offers early modeling, preliminary preparation plan trial site initiation, on-site execution, and project management services. SMO ClinPlus CO.,LTD. was founded in 2009 and is based in Shanghai, China.